English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Born of the union of biology, chemistry, and physics, molecular biology is a basic science with intense practical and commercial consciousness. It was barely six decades old on June 26, 2000, when U.S. president Bill Clinton and British prime minister Tony Blair jointly announced its crowning achievement, a draft for the human genome, the “book of life” listing all human genes. “Today we are leaning the language in which God created life,” proclaimed Clinton. Others had more mundane concerns. “The genomic gold rush” flashed on the cover of BusinessWeek. It was not the first gold rush since the late 1970s, when molecular biology spawned the biotechnology industry that brought human insulin, growth hormone, and other biological drugs and diagnostic tools. Many more are promised. However, the envisioned biomedical revolution is slow in coming, partly because disease phenomena are so complex. To combat the complexity, science is increasingly polling knowledge scattered among various traditional branches.

Scientific convergence in the birth of molecular biology